Global Bioinformatics Market All Set to Register a CAGR of 21.2% According to The Newly Added Report at Analyze Future

Portland, Oregon (PRWEB UK) 3 June 2014

Analyze Future publishes a latest report titled "Bioinformatics Market - Global Industry Analysis, Size, Growth Trends, Share, Opportunities and Forecast."

The study suggest that the global Bioinformatics market would touch a figure of $12.8 billion by 2020, registering a CAGR of 21.2% during 2014-2020.

To view complete report, visit http://www.analyzefuture.com/bioinformatics-market.

Bioinformatics refers to a system that manages biological data. Development of bioinformatics would prove to be beneficial in numerous fields such as drug discovery and development, molecular medicine, gene therapy, personalized medicines, preventive medicines, etc.

Rising integrated data need, demand for drug development and discovery, greater focus in genomics & proteomics, and encouraging government policies are propelling the growth of market. The limitations for the growth of this market are the need for skilled personnel, saturation of the pharmaceutical sector and lack of common data formats.

The report segments the bioinformatics technology and services market into knowledge management tools, bioinformatics platforms and bioinformatics services. Due to higher use of bioinformatics tools in various genomic studies, it generated maximum revenue in the year 2013. However, the report expects the knowledge management tools to generate maximum revenue by 2020. This can be credited to the rising data integration need, increase in clinical trials and growth in the proteomic data.

Browse related report

Global stem cell umbilical cord blood (UCB) market: Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Current market for cord blood therapeutics accounts for $6.5 billion, which is expected to grow at 33.4% CAGR from 2013-2020. Other segments of this market include adult stem cell and embryonic stem cells. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies.

See the stem cell umbilical cord blood (UCB) market report at http://www.analyzefuture.com/stem-cell-umbilical-cord-blood-UCB-market.

View post:
Global Bioinformatics Market All Set to Register a CAGR of 21.2% According to The Newly Added Report at Analyze Future